Priovant


Priovant Therapeutics is a clinical-stage biotechnology company focused on delivering novel therapies for autoimmune diseases with the heaviest patient burdens.

Employees

11-50

Links


Org chart

Collapse
Paul Mudd
Chief Development Officer
George Kokkines
General Counsel
Daniel Herz-Roiphe
SVP, Finance, Operations & Technology
Matt Cascino
SVP, Clinical Development
Megan Huey
Head, People
Whitney Holmes
Conference Planner & Executive Assistant to the CEO
Megan H.
Head Of People
Bruce Stevens
SVP, Quality

Board & advisors

Eric Venker
Director
Frank Torti
Executive Chairman


Offices